The Evolving Role of Genotypic Data

Ruben A. Mesa, MD

Video Categories: Myelofibrosis

Dr. Mesa recognizes that although genotypic data is not yet being used to select treatment choice or dosing in myelofibrosis, it is used to address the issues of prognosis and burden of disease.
March 31, 2015

Integrating Cost into Treatment

According to Alexander Bastian, it’s very difficult to determine how to integrate cost into the equation of cancer care. He explains that cost should be considered early on and uses Dr. Zafar’s term of financial toxicity, meaning the burden of cost can be as bad or worse than a physical [ Read More ]

October 6, 2014

PV Support Groups and Resources

Hear Emily Knight describe the various support groups available for patients with polycythemia vera and the resources available to themSupported through funding from Incyte